| Literature DB >> 21888904 |
Yoshiaki Tamura1, Yuko Chiba, Toshihiro Tanioka, Nobuyuki Shimizu, Shohei Shinozaki, Marina Yamada, Kentaro Kaneki, Seijiro Mori, Atsushi Araki, Hideki Ito, Masao Kaneki.
Abstract
Nitric oxide (NO) has been implicated in pancreatic β-cell death in the development of diabetes. The mechanisms underlying NO-induced β-cell death have not been clearly defined. Recently, receptor-interacting protein-1 (RIP1)-dependent necrosis, which is inhibited by necrostatin-1, an inhibitor of RIP1, has emerged as a form of regulated necrosis. Here, we show that NO donor-induced β-cell death was inhibited by necrostatin-1. Unexpectedly, however, RIP1 knockdown neither inhibited cell death nor altered the protective effects of necrostatin-1 in NO donor-treated β-cells. These results indicate that NO donor induces necrostatin-1-inhibitable necrotic β-cell death independent of RIP1. Our findings raise the possibility that NO-mediated β-cell necrosis may be a novel form of signal-regulated necrosis, which play a role in the progression of diabetes.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21888904 PMCID: PMC3304503 DOI: 10.1016/j.febslet.2011.08.028
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124